Depression, psychosocial factors, and laboratory routine testing in people living with HIV in Northeastern Mexico: prevalence, correlations, and its associations
DOI:
https://doi.org/10.25118/2763-9037.2023.v13.921Keywords:
depression, HIV, viral load, CD4 cell countAbstract
Introduction: Depression is up to five times more prevalent in people living with HIV (PLWHIV). There are neurohormonal, virological and psychosocial factors involved and it is associated with antiretroviral treatment non-adherence, decreased life expectancy, faster progression to AIDS and premature death. Studies support that with lower CD4 levels, and the higher viral load (VL), depression increases. Objective: To establish whether there is a correlation and association between the VL and CD4 count with depression and its symptoms in PLWHIV. Method: Under follow-up in the Infectious Disease outpatient clinic a survey of sociodemographic variables, and a Beck's Depression Inventory (BDI) was applied to the study subjects, whose results were analyzed using Rho Spearman (rs) and Chi Squared test (X2) with VL and CD4 levels. Results: 137 individuals were included, from 18-73 years, which 97 (70.8%) were male assigned at birth. The prevalence of depression reported, was 25.5%. A positive correlation was found between VL and BDI score, and a negative correlation between BDI score and CD4. In addition, correlation was found between VL, and depressive symptoms such as guilt, discouragement and self-image perception. These symptoms were strongly associated with death wishes, previous suicide attempts, and treatment non-dherence. Conclusion: VL may have implication in depression and its symptoms in this population, so their control is extremely important to prevent depressive episodes and suicidal behavior and prolong treatment adherence.
Downloads
Metrics
References
Page-Shafer K, Delorenze GN, Satariano WA, Winkelstein W Jr. Comorbidity and survival in HIV-infected men in the San Francisco men's health survey. Ann Epidemiol. 1996;6(5):420-30. https://doi.org/10.1016/s1047-2797(96)00064-6 - PMID:8915473
Nanni MG, Caruso R, Mitchell AJ, Meggiolaro E, Grassi L. Depression in HIV infected patients: a review. Curr Psychiatry Rep. 2015;17:530. https://doi.org/10.1007/s11920-014-0530-4 PMID:25413636
Meade CS, Sikkema KJ. HIV risk behavior among adults with severe mental illness: a systematic review. Clin Psychol Rev. 2005;25(4):433-57. https://doi.org/10.1016/j.cpr.2005.02.001 PMID:15914265
Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med. 2008;70(5):539-45. https://doi.org/10.1097/psy.0b013e3181777a5f - PMID:18519880
Rezaei S, Ahmadi S, Rahmati J, Hosseinifard H, Dehnad A, Aryankhesal A, Shabaninejad H, Ghasemyani S, Alihosseini S, Bragazzi NL, Raoofi S, Kiaee ZM, Ghashghaee A. Global prevalence of depression in HIV/AIDS: a systematic review and meta-analysis. BMJ Support Palliat Care. 2019;9(4):404-12. https://doi.org/10.1136/bmjspcare-2019-001952 - PMID:31537580
Iyanda AE, Chima-Adaralegbe N, Adeleke R, Lu Y. Covariation of suicide and HIV in 186 countries: a spatial autoregressive and multiscale geographically weighted regression analyses. J Public Health. 2022;30:1545-55. https://doi.org/10.1007/s10389-020-01436-3
Pelton M, Ciarletta M, Wisnousky H, Lazzara N, Manglani M, Ba DM, Chinchillli VM, Du P, Ssentongo AE, Ssentongo P. Rates and risk factors for suicidal ideation, suicide attempts and suicide deaths in persons with HIV: a systematic review and meta-analysis. Gen Psychiatr. 2021;34:e100247. https://doi.org/10.1136/gpsych-2020-100247 - PMID:33912798 PMCID:PMC8042999
Del Guerra FB, Fonseca JL, Figueiredo VM, Ziff EB, Konkiewitz EC. Human immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways. J Neurovirol. 2013;19(4):314-27. https://doi.org/10.1007/s13365-013-0177-7 - PMID:23868513
Yousuf A, Mohd Arifin SR, Musa R, Md Isa ML. Depression and HIV disease progression: a mini-review. Clin Pract Epidemiol Ment Health. 2019;15:153-9. https://doi.org/10.2174/1745017901915010153 - PMID:32174997 - PMCID:PMC7040472
Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46-56. https://doi.org/10.1038/nrn2297 - PMID:18073775 - PMCID:PMC2919277
Dantzer R, O'Connor JC, Lawson MA, Kelley KW. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology. 2011;36(3):426-36. https://doi.org/10.1016/j.psyneuen.2010.09.012 - PMID:21041030 - PMCID:PMC3053088
Ehrenkranz PD, Baptiste SL, Bygrave H, Ellman T, Doi N, Grimsrud A, Jahn A, Kalua T, Nyirenda RK, Odo MO, Ondoa P, Vojnov L, Holmes CB. The missed potential of CD4 and viral load testing to improve clinical outcomes for people living with HIV in lower-resource settings. PLoS Med. 2019;16(5):e1002820. https://doi.org/10.1371/journal.pmed.1002820 - PMID:31141516 PMCID:PMC6541248
México, Instituto Mexicano del Seguro Social. Plataforma Interactiva VIH-IMSS. Ciudad de México: Instituto Mexicano del Seguro Social; [citado el 6 de julio de 2022]. https://www.imss.gob.mx/pivihimss
Gutiérrez-Velilla E, Pineirúa-Menéndez A, Ávila-Ríos S, Caballero-Suárez NP. Clinical follow-up in people living with HIV during the covid-19 pandemic in Mexico. AIDS Behav. 2022;26(8):2798-812. https://doi.org/10.1007/s10461-022-03626-4 - PMID:35190942 -PMCID:PMC8860257
Shafer AB. Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung. J Clin Psychol. 2006;62(1):123-46. https://doi.org/10.1002/jclp.20213 PMID:16287149
Rodríguez-Pérez V, Pineirua Menéndez A, Ramírez-Rentería C, Mata Marín JA. Beck Depression Inventory (BDI-IA) adapted for HIV: psychometric properties, sensitivity & specificity in depressive episodes, adjustment disorder & without symptomatology. Salud Ment (Mex). 2021;44(6):287-94. https://doi.org/10.17711/SM.0185-3325.2021.037
Taniguchi T, Shacham E, Onen NF, Grubb JR, Overton ET. Depression severity is associated with increased risk behaviors and decreased CD4 cell counts. AIDS Care. 2014;26(8):1004-12. https://doi.org/10.1080/09540121.2014.880399 - PMID:24479743 -PMCID:PMC4349330
Olose EO, Busari CO, Adubina BI, Ogunnubi OP, Ekpe EE. CD4 cell count and depression among patients with human immunodeficiency virus attending a general hospital in South-South, Nigeria. World J Med Sci. 2021;18(2):42-50. https://www.idosi.org/wjms/18(2)21/1.pdf
Khare RL, Rajpoot V, Dubey S. Evaluation of depression and anxiety and its association with CD4 count among HIV patients taking antiretroviral therapy. J Evol Med Dent Sci. 2020;9(31):2223-7. https://doi.org/10.14260/jemds/2020/483
Checa A, Navas E, Valencia V, Alcívar J. Depression is associated with CD4 levels in people living with HIV in Ecuador. Rev Mex Neurocienc. 2021;22(6):224-8. https://doi.org/10.24875/RMN.21000032
Redman KN, Karstaedt AS, Scheuermaier K. Increased CD4 counts, pain and depression are correlates of lower sleep quality in treated HIV positive patients with low baseline CD4 counts. Brain Behav Immun. 2018;69:548-55. https://doi.org/10.1016/j.bbi.2018.02.002 PMID:29452219
Martins C, Coelho FMDC, Pinheiro RT, Motta JVDS, Souza LDM, Pinheiro CAT, Kelbert EF, Souza MS, Pinheiro LMS, Pinheiro KAT. People living with HIV/AIDS: body image and its important associations with mental health and BMI. Psychol Health Med. 2020;25(8):1020-8. https://doi.org/10.1080/13548506.2019.1691244 - PMID:31735072
Qin K, Zeng J, Liu L, Cai Y. Effects of cognitive behavioral therapy on improving depressive symptoms and increasing adherence to antiretroviral medication in people with HIV. Front Psychiatry. 2022;13:990994. https://doi.org/10.3389/fpsyt.2022.990994 -PMID:36440403 PMCID:PMC9682157
Cabrera DM, Diaz MM, Grimshaw A, Salvatierra J, Garcia PJ, Hsieh E. Aging with HIV in Latin America and the Caribbean: a systematic review. Curr HIV/AIDS Rep. 2021;18(1):1-47. https://doi.org/10.1007/s11904-020-00538-7 - PMID:33400168 PMCID:PMC8059362
Henry RS, Hoetger C, Rabinovitch AE, Aguayo Arelis A, Rabago Barajas BV, Perrin PB. Discrimination, mental health, and suicidal ideation among sexual minority adults in Latin America: considering the roles of social support and religiosity. Trauma Care. 2021;1(3):143-61. https://doi.org/10.3390/traumacare1030013
Bil JP, Zuure FR, Alvarez-Del Arco D, Prins JM, Brinkman K, Leyten E, van Sighem A, Burns F, Prins M. Disparities in access to and use of HIV-related health services in the Netherlands by migrant status and sexual orientation: a cross-sectional study among people recently diagnosed with HIV infection. BMC Infect Dis. 2019;19:906. https://doi.org/10.1186/s12879-019-4477-2 PMID:31664925 - PMCID:PMC6819557
Pence BW, O'Donnell JK, Gaynes BN. Falling through the cracks: the gaps between depression prevalence, diagnosis, treatment, and response in HIV care. AIDS. 2012;26(5):656-8. https://doi.org/10.1097/qad.0b013e3283519aae - PMID:22398574 - PMCID:PMC3691843
Marando F, Gualberti G, Costanzo AM, di Luzio Paparatti U, Franzetti M, Ammassari A, Antinori A, Galli M. Discrepancies between physician's perception of depression in HIV patients and self-reported CES-D-20 assessment: the DHIVA study. AIDS Care. 2016;28(2):147-59. https://doi.org/10.1080/09540121.2015.1080794 - PMID:26461177 - PMCID:PMC4732457
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Manuel Ángel Bermúdez Barrera, Ruth Cruz Santos , Abdías Alonso González, Juan Antonio Escobar Félix
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
